These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7865891)

  • 1. Chronic morphine treatment suppresses CTL-mediated cytolysis, granulation, and cAMP responses to alloantigen.
    Carpenter GW; Garza HH; Gebhardt BM; Carr DJ
    Brain Behav Immun; 1994 Sep; 8(3):185-203. PubMed ID: 7865891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine suppresses the alloantigen-driven CTL response in a dose-dependent and naltrexone reversible manner.
    Scott M; Carr DJ
    J Pharmacol Exp Ther; 1996 Aug; 278(2):980-8. PubMed ID: 8768756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment with beta-funaltrexamine blocks morphine-mediated suppression of CTL activity in alloimmunized mice.
    Carpenter GW; Carr DJ
    Immunopharmacology; 1995 Mar; 29(2):129-40. PubMed ID: 7775156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl peptidase I is enriched in granules of in vitro- and in vivo-activated cytotoxic T lymphocytes.
    Brown GR; McGuire MJ; Thiele DL
    J Immunol; 1993 Jun; 150(11):4733-42. PubMed ID: 8496587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine-induced suppression of cytotoxic T lymphocyte activity in alloimmunized mice is not mediated through a naltrindole-sensitive delta opioid receptor.
    Carr DJ; Carpenter GW
    Neuroimmunomodulation; 1995; 2(1):44-53. PubMed ID: 7614260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytotoxic T lymphocyte and natural killer cell-mediated lysis by O,S,S,-trimethyl phosphorodithioate is at an early postrecognition step.
    Rodgers KE; Grayson MH; Ware CF
    J Immunol; 1988 Jan; 140(2):564-70. PubMed ID: 3257244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
    J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of exogenous corticosterone treatment on alloantigen-specific cytotoxic T lymphocyte activity in mice.
    DeKrey GK; Kerkvliet NI
    J Pharmacol Exp Ther; 1995 May; 273(2):823-9. PubMed ID: 7752086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
    Makrigiannis AP; Hoskin DW
    J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor.
    Wang J; Charboneau R; Balasubramanian S; Barke RA; Loh HH; Roy S
    J Leukoc Biol; 2002 May; 71(5):782-90. PubMed ID: 11994502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice.
    Kägi D; Ledermann B; Bürki K; Seiler P; Odermatt B; Olsen KJ; Podack ER; Zinkernagel RM; Hengartner H
    Nature; 1994 May; 369(6475):31-7. PubMed ID: 8164737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cyclic AMP in modulating cytotoxic T lymphocytes. II. Sequential changes during culture in responsiveness of cytotoxic lymphocytes to cyclic AMP-active agents.
    Plaut M; Marone G; Gillespie E
    J Immunol; 1983 Dec; 131(6):2945-52. PubMed ID: 6315818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute exposure to morphine suppresses cytotoxic T-lymphocyte activity.
    Carpenter GW; Breeden L; Carr DJ
    Int J Immunopharmacol; 1995 Dec; 17(12):1001-6. PubMed ID: 8964649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
    Zhu XL; Chen AF; Lin ZB
    J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cytotoxic cell activities by a novel cyclic disulfide compound, SA3443 in vivo.
    Sasano M; Tanaka M; Nakata K; Mita S
    Immunopharmacol Immunotoxicol; 1991; 13(1-2):121-33. PubMed ID: 1770215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen recognition by CTL is dependent upon ectoATPase activity.
    Dombrowski KE; Ke Y; Thompson LF; Kapp JA
    J Immunol; 1995 Jun; 154(12):6227-37. PubMed ID: 7759860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of immune status induced by the sympathetic nervous system: immunomodulatory effects of DMPP alone and in combination with morphine.
    Fecho K; Maslonek KA; Dykstra LA; Lysle DT
    Brain Behav Immun; 1993 Sep; 7(3):253-70. PubMed ID: 8219413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of T cell-mediated cytotoxicity by anti-inflammatory steroids.
    Schleimer RP; Jacques A; Shin HS; Lichtenstein LM; Plaut M
    J Immunol; 1984 Jan; 132(1):266-71. PubMed ID: 6606668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity.
    Freier DO; Fuchs BA
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1127-33. PubMed ID: 7932161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
    J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.